Gliosarcoma

Patients suffering from recently diagnosed malignant brain tumors called glioblastoma multiforme or a rare variant called gliosarcoma may be eligible to participate in a Phase II clinical trial at Cedars-Sinai Medical Center that combines two innovative drugs. ❋ Editors (2010)

The researchers have demonstrated that they could get the small molecule calcein, the bovine serum albumin protein and plasmid DNA through the cell membranes of human prostate cancer cells and rat gliosarcoma cells using this technique. ❋ Unknown (2010)

Anticancer Drugs 1992 Oct; 3 (5): 525-530 Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. ❋ Amp;34; (2010)

Dilmanian FA, Button TM, Le Duc G, Zhong N, Pena LA, et al. (2002) Response of rat intracranial 9L gliosarcoma to microbeam radiation therapy. ❋ Raphaël Serduc Et Al. (2010)

The addition of Tarceva® (erlotinib) and Temodar® (temozolomide) during and after radiation therapy improves survival in patients with newly diagnosed glioblastoma multiforme (GBM) and gliosarcoma, according to the results of a study published in the

a squamous cell carcinoma (HTB 43) and a gliosarcoma (9L) cell line at 2-8 micrograms/ml concentrations. ❋ Amp;34; (2010)